Takeda’s Entyvio Bests Humira in Head-to-Head UC Study
New Phase 3 STELARA® (ustekinumab) Data Show Positive Results As Maintenance Therapy In Adults With Moderate To Severe Ulcerative Colitis
Amgen, Entera to Partner on Oral Drugs for Inflammatory Disease, Other “Serious” Illnesses
FDA Approves Humira Biosimilar That Won’t Be Available Until 2023
Janssen's Stelara shows promise across two dosages in ulcerative colitis
Έγκριση του tofacitinib citrate στην Ευρώπη για την ελκώδη κολίτιδα
New Jersey-based multinational MSD have announced that the European Commission (EC) has approved Simponi (golimumab) for early dose optimisation in ulcerative colitis (UC) for patients with body weight less than 80kg who do not respond adequately to induction therapy. The approval follows a positive opinion issued by the Committee for Medicinal Products for Human … Συνεχίστε να διαβάζετε MSD’s ulcerative colitis drug scores expanded indication in Europe.